Plain-English translation of NCT06970080 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Asthma research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This study is testing whether the shape and structure of your airways can predict how well you'll respond to different types of steroid treatment for asthma. Some people with asthma don't respond well to standard inhaled steroids, and researchers believe this may be because of how their airways are shaped, which affects how the medication reaches the inflamed areas. The study will compare how your asthma improves when you double your inhaled steroid dose, or if needed, switch to oral steroids.
Many people with asthma don't get adequate control with standard inhaled steroids, but doctors don't yet have a reliable way to predict who will benefit from higher doses versus a different type of medication. This study aims to understand whether airway shape and function can help guide better, more personalized asthma treatment.
You likely qualify if…
You likely don't qualify if…
You will be in this study for 12 weeks or longer. First, you'll have screening visits where your airway function will be tested and samples collected to confirm you have the type of asthma being studied. During Phase I, you'll continue your current asthma medication but double your inhaled steroid dose for 12 weeks. Researchers will take MRI images of your airways and monitor how well your asthma improves. If your asthma remains uncontrolled after Phase I, you may move to Phase II where you would receive a short course of oral steroids instead.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Canada